Vascular Therapies: a focused, experienced, and passionate team driven by the goal of improving the lives of patients. Vascular Therapies (VT) is a biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring an AV fistula for dialysis. Our lead product candidate, containing sirolimus, has received orphan drug designations ...
Vascular Therapies: a focused, experienced, and passionate team driven by the goal of improving the lives of patients. Vascular Therapies (VT) is a biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring an AV fistula for dialysis. Our lead product candidate, containing sirolimus, has received orphan drug designations in the U.S. and E.U. for the dialysis vascular access indications.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.